These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25887903)

  • 41. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration.
    Huang H; Koelle P; Fendler M; Schröttle A; Czihal M; Hoffmann U; Conrad M; Kuhlencordt PJ
    Atherosclerosis; 2014 Jul; 235(1):213-22. PubMed ID: 24858340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression profile of ADRP in macrophages and foam cells].
    Song Y; Li H; Zhang LY; Ye Q; Li Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):309-11. PubMed ID: 19351497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
    Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
    Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells.
    Katabuchi H; Yih S; Ohba T; Matsui K; Takahashi K; Takeya M; Okamura H
    Med Electron Microsc; 2003 Dec; 36(4):253-62. PubMed ID: 16228658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis.
    Tsou CY; Chen CY; Zhao JF; Su KH; Lee HT; Lin SJ; Shyue SK; Hsiao SH; Lee TS
    Acta Physiol (Oxf); 2014 Apr; 210(4):799-810. PubMed ID: 24299003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased oxidative stress in foam cells obtained from hemodialysis patients.
    Gonçalves MS; Fabris BA; Brinholi FF; Bortolasci CC; Watanabe MA; Oliveira KB; Delfino VD; Lavado EL; Barbosa DS
    Hemodial Int; 2013 Apr; 17(2):266-74. PubMed ID: 22928784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
    Chono S; Morimoto K
    J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes.
    Hägg DA; Jernås M; Wiklund O; Thelle DS; Fagerberg B; Eriksson P; Hamsten A; Olsson B; Carlsson B; Carlsson LM; Svensson PA
    Int J Mol Med; 2008 Jun; 21(6):697-704. PubMed ID: 18506362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular pathways used by platelets to initiate and accelerate atherogenesis.
    Lindemann S; Krämer B; Daub K; Stellos K; Gawaz M
    Curr Opin Lipidol; 2007 Oct; 18(5):566-73. PubMed ID: 17885429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glomerular foam cells in kidney allograft.
    Zienowicz B; Kruś S; Hagel E
    Int Urol Nephrol; 1978; 10(3):237-44. PubMed ID: 357322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine gene expression during monocyte macrophage maturation and foam cell transformation.
    Hogan C; Collins P; Sexton D
    Biochem Soc Trans; 1998 Feb; 26(1):S9. PubMed ID: 10909767
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus.
    Kamanna VS; Roh DD; Kirschenbaum MA
    Histol Histopathol; 1998 Jan; 13(1):169-79. PubMed ID: 9476647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage complexity in human atherosclerosis: opportunities for treatment?
    Biessen EAL; Wouters K
    Curr Opin Lipidol; 2017 Oct; 28(5):419-426. PubMed ID: 28759472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Renal disease with an unusual histological aspect (foam cell glomerulopathy)].
    JIMENEZ DIAZ C; OLIVA H; GARRIDO M
    Rev Clin Esp; 1961 Oct; 83():51-3. PubMed ID: 14451817
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interstitial foam cell infiltrations in the course of renal diseases].
    MIROUZE J; PAGES A
    J Urol Medicale Chir; 1959 Sep; 65():650-9. PubMed ID: 14422870
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of uniaxial, cyclic stretch on the morphology of monocytes/macrophages in culture.
    Matsumoto T; Delafontaine P; Schnetzer KJ; Tong BC; Nerem RM
    J Biomech Eng; 1996 Aug; 118(3):420-2. PubMed ID: 8872266
    [No Abstract]   [Full Text] [Related]  

  • 58. Cryptococcosis, tuberculosis, and a kidney cancer fail to fit the atherosclerosis paradigm for foam cell lipid content.
    Guerrini V; Prideaux B; Khan R; Subbian S; Wang Y; Sadimin E; Pawar S; Ukey R; Singer EA; Xue C; Gennaro ML
    bioRxiv; 2024 Jul; ():. PubMed ID: 37333211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spontaneous occurrence of pulmonary foam cells in Fischer 344 rats.
    Shibuya K; Tajima M; Yamate J; Sutoh M; Kudow S
    Nihon Juigaku Zasshi; 1986 Apr; 48(2):413-7. PubMed ID: 3712903
    [No Abstract]   [Full Text] [Related]  

  • 60. Hereditary nephropathy, deafness and renal foam cells.
    WHALEN RE; HUANG S; PESCHEL E; McINTOSH HD
    Am J Med; 1961 Aug; 31():171-86. PubMed ID: 13784720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.